The use of real time rtPCR to quantify inflammatory mediator expression in leukocytes from patients with severe sepsis

Anaesthesia and Intensive Care

Volumn 32, Issue 6, 2004, Pages 746-755

  Kalkoff, M ^a,b   Cursons, R T ^a   Sleigh, J W ^a,b   Jacobson, G M ^a  

^a UNIVERSITY OF WAIKATO   (New Zealand)

^b WAIKATO HOSPITAL   (New Zealand)

Author keywords

Cytokine; Intensive care; mRNA expression; Sepsis: Polymerase chain reaction

Indexed keywords

ANTIBIOTIC AGENT; AUTACOID; BETA 2 MICROGLOBULIN; CD11B ANTIGEN; CD14 ANTIGEN; COMPLEMENT COMPONENT C5A RECEPTOR; GAMMA INTERFERON; GELATINASE B; HEAT SHOCK PROTEIN; HEAT SHOCK PROTEIN 70; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERLEUKIN 1 RECEPTOR ASSOCIATED KINASE 1; INTERLEUKIN 12; INTERLEUKIN 1BETA; INTERLEUKIN 6; INTERLEUKIN 8; MESSENGER RNA; MYELOPEROXIDASE; PLATELET DERIVED GROWTH FACTOR; RECEPTOR INTERACTING PROTEIN 2; TOLL LIKE RECEPTOR 2; TOLL LIKE RECEPTOR 4; TRANSCRIPTION FACTOR; UNCLASSIFIED DRUG;

ARTICLE; BLOOD SAMPLING; BURN; CLINICAL ARTICLE; CONTROLLED STUDY; CORRELATION ANALYSIS; DIAGNOSTIC PROCEDURE; DISCRIMINANT ANALYSIS; DISEASE SEVERITY; DOWN REGULATION; FEMALE; GENE CONTROL; GENE EXPRESSION; HUMAN; HUMAN CELL; IMMUNE RESPONSE; IMMUNOMODULATION; IMMUNOTHERAPY; LEUKOCYTE; LINEAR SYSTEM; MALE; MITOCHONDRION; MUSCULOSKELETAL DISEASE; NUCLEOTIDE SEQUENCE; OUTCOMES RESEARCH; PATIENT MONITORING; PERITONITIS; PNEUMONIA; QUANTITATIVE ANALYSIS; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SEPSIS; STATISTICAL SIGNIFICANCE; TREATMENT PLANNING; UPREGULATION; VARIANCE; VOLUNTEER;

EID: 11444258210     PISSN: 0310057X     EISSN: None     Source Type: Journal    
DOI: 10.1177/0310057x0403200603     Document Type: Article

References (50)

1. Delogu G, Lo Bosco L, Marandola M et al. Heat shock protein (HSP70) expression in septic patients. J Crit Care 1997; 12:188-192.
2. de Werra I, Zanetti G, Jaccard C et al. CD14 expression on monocytes and TNF alpha production in patients with septic shock, cardiogenic shock or bacterial pneumonia. Swiss Med Wkly 2001; 131:3-4, 35-40.
3. Wu RQ, Xu Y, Song X, Meng X. Gene expression of adhesion molecules in pulmonary and hepatic microvascular endothelial cells during sepsis. Chin J Traumatol 2002; 5:146-150.
4. Cabioglu N, Bilgic S, Deniz G et al. Decreased cytokine expression in peripheral blood leukocytes of patients with severe sepsis. Arch Surg 2002; 137:1037-1043.
5. Cohen J. The immunopathogenesis of sepsis. Nature 2002; 4:20:885-891.
6. Hotchkiss RS, Karl IE. The pathophysiology and treatment of sepsis. N Engl J Med 2003; 348:138-150.
7. Abraham. Why immunomodulatory therapies have not worked in sepsis. Intensive Care Med 1999; 25:556-566.
8. Doecke WD, Randow F, Syrbe U et al. Monocyte deactivation in septic patients: restoration by IFN-gamma treatment. Nat Med 1997; 3:678-681.
9. Weiss ST, Martinez F. University of Arizona Respiratory Sciences Center, Boston Children's Hospital Informatics SNP per, Brighams & Women's Hospital Channing Laboratory: Innate Immunity in Heart, Lung and Blood Disease Programs for Genomic Applications. http://www.innateimmunity.net/. December 2002
10. Rainen L, Oelmueller U, Jurgensen S et al. Stabilization of mRNA expression in whole blood samples. Clin Chem 2002; 48:1883-1890.
11. Livak KJ, Schmittgen TD. Analysis of relative gene expression data using real-time quantitative PCR and the 2-CT method. Methods 2001; 25:402-408.
12. Ertel W, Kremer JP, Kenney J et al. Downregulation of proinflammatory cytokine release in whole blood from septic patients. Blood 1995; 85:1341-1347.
13. Wu RQ, Xu YX, Song XH, Chen LJ, Meng XJ. Relationship between cytokine mRNA expression and organ damage following cecal ligation and puncture. World J Gastroenterol 2002; 8:131-134.
14. Riedemann NC, Neff TA, Guo RF et al. Protective effects of IL-6 blockade in sepsis are linked to reduced C5a receptor expression. J Immunol 2003; 170:503-507.
15. Galley HF, Dubbels AM, Webster NR. The effect of midazolam and propofol on interleukin-8 from human polymorphonuclear leukocytes. Anesth Analg 1998; 86:1289-1293.
16. Lin KJ, Lin J, Hanasawa K, Tani T, Kodama M. Interleukin-8 as a predictor of the severity of bacteremia and infectious disease. Shock 2000; 14:95-100.
17. Yeh FL, Lin WL, Shen HD, Fang RH. Changes in circulating levels of interleukin 6 in burned patients. Burns 1999; 25:131-136.
18. Hamano K, Gohra H, Noda H et al. Increased serum interleukin-8: correlation with poor prognosis in patients with postoperative multiple organ failure. World J Surg 1988; 22:1077-1081.
19. Damas P, Canivet JL, de Groote D et al. Sepsis and serum cytokine concentrations. Crit Care Med 1997; 25:405-412.
20. Bustin SA. Quantification of mRNA using real-time reverse transcription PCR (RT-PCR): trends and problems. J Mol Endocrinol 2002; 29:23-39.
21. Giulietti A, Overbergh L, Valckx D, Decallonne B, Bouillon R, Mathieu C. An overview of real-time quantitative PCR: applications to quantify cytokine gene expression. Methods 2001; 25:386-401.
22. Lupberger J, Kreuzer KA, Baskaynak G, Peters UR, le Coutre P, Schmidt CA. Quantitative analysis of beta-actin, beta-2-microglobulin and porphobilinogen deaminase mRNA and their comparison as control transcripts for RT-PCR. Mol Cell Probes 2002; 16:25-30.
23. Schmittgen TD, Zakrajsek BA. Effect of experimental treatment on housekeeping gene expression: validation by real-time, quantitative RT-PCR. J Biochem Biophys Methods 2000; 46:69-81.
24. Whitney AR, Diehn M, Popper SJ et al. Individuality and variation in gene expression patterns in human blood. Proc Natl Acad Sci USA 2003; 100:1896-1901.
25. Yassen KA, Galley HF, Webster NR. Matrix metalloproteinase-9 concentrations in critically ill patients. Anaesthesia 2001; 56:729-732.
26. Nakamura T, Ebihara I, Shimada N, Shoji H, Koide H. Modulation of plasma metalloproteinase-9 concentrations and peripheral blood monocyte mRNA levels in patients with septic shock: effect of fiber-immobilized polymyxin B treatment. Am J Med Sci 1998; 316:355-360.
27. Gray GD, Hasslen SR, Ember JA et al. Receptors for the chemoattractants C5a and IL-8 are clustered on the surface of human neutrophils. J Histochem Cytochem 1997; 45:1461-1467.
28. Zwirner J, Fayyazi A, Gotze O. Expression of the anaphylatoxin C5a receptor in non-myeloid cells. Mol Immunol 1999; 36:877-884.
29. Kobayashi K, Inohara N, Hernandez LD et al. RICK/Rip2/CARDIAK mediates signalling for receptors of the innate and adaptive immune systems. Nature 2002; 416:6877, 194-199.
30. Chin AI, Dempsey PW, Bruhn K, Miller JF, Xu Y, Cheng G. Involvement of receptor-interacting protein 2 in innate and adaptive immune responses. Nature 2002; 416:6877, 190-194.
31. Rigato O, Salomao R. Impaired production of interferon-gamma and tumor necrosis factor-alpha but not of interleukin 10 in whole blood of patients with sepsis. Shock 2003; 19:113-116.
32. Tasaka S, Ishizaka A, Yamada W et al. Effect of CD14 blockade on endotoxin-induced acute lung injury in mice. Am J Respir Cell Mol Biol 2003; 29:252-258. Epub 2003 Mar 14
33. Stordeur P, Zhou L, Goldman M. Analysis of spontaneous mRNA cytokine production in peripheral blood. J Immunol Methods 2002; 261:195-197.
34. Duvigneau JC, Hartl RT, Teinfalt M, Gemeiner M. Delay in processing porcine whole blood affects cytokine expression. J Immunol Methods 2003; 272:11-21.
35. Netea MG, an der Meer JW, van Deuren M, Kullberg JB. Proinflammatory cytokines and sepsis syndrome: not enough, or too much of a good thing? Trends Immunol 2003; 24:254-258.
36. Chinnaiyan AM, Huber-Lang M, Kumar-Sinha C et al. Molecular signatures of sepsis: multiorgan gene expression profiles of systemic inflammation. Am J Pathol 2001; 159:1199-1209.
37. Haddad J. Cytokines and related receptor-mediated signaling pathways. Biochem Biophys Res Commun 2002; 297:700-713.
38. Ingalls RR, Monks BG, Savedra R Jr et al. CD11/CD18 and CD14 share a common lipid a signaling pathway. J Immunol 1998; 161:5413-5420.
39. Tak PP, Firestein GS. NF-kappaB: a key role in inflammatory diseases. J Clin Invest 2001; 107:7-11.
40. Wang H, Yang H, Czura CJ, Sama AE, Tracey KJ. HMGB1 as a late mediator of lethal systemic inflammation. Am J Respir Crit Care Med 2001; 164:1768-1773.
41. Strieter RM, Belperio JA, Keane MP. Cytokines in innate host defense in the lung. J Clin Invest 2002; 109:699-705.
42. Riedeman NC, Guo RF, Neff TA et al. Increased C5a receptor expression in sepsis. J Clin Invest 2002; 110:101-108.
43. Gerard C. Complement C5a in the sepsis syndrome - too much of a good thing? N Engl J Med 2003; 348:167-169.
44. Opal SM, DePalo VA. Anti-inflammatory cytokines. Chest 2000; 117:1162-1172.
45. Kaplanski G, Marin V, Montero-Julian F, Mantovani A, Farnarier C. IL-6: a regulator of the transition from neutrophil to monocyte recruitment during inflammation. Trends Immunol 2003; 24:25-29.
46. De Maio A. Heat shock proteins: facts, thoughts, and dreams. Shock 1999; 11:1-12.
47. Takeuchi O, Hoshino K, Kawai T et al. Differential roles of TLR2 and TLR4 in recognition of gram-negative and gram-positive bacterial cell wall components. Immunity 1999; 11:443-451.
48. Cohen J. TREM-1 in sepsis. Lancet 2001; 358:776-778.
49. Bouchon A, Facchetti F, Weigand MA, Colonna M. TREM-1 amplifies inflammation and is a crucial mediator of septic shock. Nature 2001; 410:6832, 1103-1107.
50. Karsai A, Muller S, Platz S. Evaluation of a homemade SYBR green I reaction mixture for real-time PCR quantification of gene expression. Biotechniques 2002; 32:4,790-792, 794-796.